Jocelyn Maragulia

Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent Infections

Carla Casulo, Jocelyn Maragulia, Andrew D. Zelenetz · Clinical Lymphoma Myeloma & Leukemia · 2012 · 296 citations · Full text

Immunohematology, Recurrent Infections, Autoimmune Disease +10

Normalization of pre-ASCT, FDG-PET imaging with second-line, non–cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma

Craig H. Moskowitz, Matthew J. Matasar, Andrew D. Zelenetz et al. · Blood · 2011 · 280 citations · Full text

Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma

Alison J. Moskowitz, Joachim Yahalom, Tarun Kewalramani et al. · Blood · 2010 · 236 citations · Full text

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma

Jonathan H. Schatz, Elisa Oricchio, Andrew L. Wolfe et al. · The Journal of Experimental Medicine · 2011 · 114 citations · Full text

Pim Kinases, Kinase Inhibitors, Pim-mediated Resistance +17

A multicentre study of primary breast diffuse large <scp>B</scp>‐cell lymphoma in the rituximab era

Peter J. Hosein, Jocelyn Maragulia, Matthew Salzberg et al. · British Journal of Haematology · 2014 · 113 citations · Full text